Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kallunk Oxide in HIV/AIDS
NCT01349062Phase 3Completed
- Sponsor
- Traditional Alternative Medicine Research
- Start
- Feb 2012
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
A Phase 3 trial of Kallunk oxide in human immunodeficiency virus infection (HIV), sponsored by Traditional Alternative Medicine Research. Started Feb 2012; status: completed.
02
Drugs
Kallunk oxide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01349062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349062.